Categories: Market Watch

GBB Drink Labs Initiates $53 Million Lawsuit Against FSD Biosciences Inc. For Trade Secret Misappropriation

Miami, FL, December 5, 2023 — GBB Drink Labs, a leader in innovative beverage solutions, has officially filed a lawsuit against FSD Biosciences Inc. in response to the blatant non-compliance with a Cease-and-Desist letter issued on April 14th, 2023. The lawsuit, formally submitted on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, seeks $53 million in damages for a material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The legal action stems from seven months of collaborative discussions between GBB Drink Labs and FSD Pharma, exploring a business opportunity related to GBB’s groundbreaking blood alcohol detoxification drink. FSD Pharma’s public disclosure of the misappropriation of GBB’s trade secrets, without crucial information, during the launch of a new research and development program has led to the initiation of legal proceedings.

The lawsuit alleges that FSD Pharma not only misused GBB’s proprietary and confidential material to attract capital and renowned entrepreneurs but also artificially inflated the price of FSD Pharma’s publicly traded stock. GBB Drink Labs, responding strongly to these actions, is seeking compensatory and punitive damages, coupled with an injunction to prevent any further unlawful disclosure and use of GBB’s trade secrets.

The case, officially titled GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC., has been assigned case number 0:23-cv-60800-AHS in the U.S. District Court for the Southern District of Florida.

For more information on the case, please visit www.sinkingstocks.com.

About GBB Drink Labs: GBB Drink Labs boasts a patented formula that accelerates the process of converting alcohol to sugar in the body, facilitating rapid blood alcohol detoxification. The company has dedicated years to developing a proprietary drink, culminating in a successful acquisition of its patents by Jupiter Wellness, Inc. The closing date for the acquisition is set for August 11th, 2023, with Jupiter Wellness proudly introducing the world’s first rapid blood alcohol detoxification product, “Safety Shot.”

Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please email at contact@etrendystock.com

BTW

Recent Posts

U-topia Launches Public Beta as Global Builders Gather for U-Hackathon

Financial technology company opens its app in more than 50 countries during FLOW Summit as…

1 day ago

From Karmayogi to the World Stage: Dr. Hemant Garg Wins “Excellence in AI for Public Policy”, Charts India’s Path to the AI Big League

Civil servant, researcher and AI pioneer tells the 3rd World AI Summit, Bengaluru, that people-first,…

1 day ago

CentFX Honored with the Most Trusted Liquidity Provider Award at Forex Expo Dubai 2026

Recognition closes two days of live trading sessions and partner meetings at Booth 081, Dubai…

1 week ago

RWA WEEK Singapore Announces New Wave of Institutional Speakers as October Event Draws Closer

Singapore, October 6, 2026 — With less than a month to go until RWA WEEK…

2 weeks ago

PropLaunch Partners with Axcera and RUBIK to Simplify Prop Firm Launches

Partnership combines operating support, technology infrastructure and specialist risk expertise for entrepreneurs launching proprietary trading…

2 weeks ago

ND SATCOM’s SKYWAN Technology Named “Government Solution of the Year” at SSGS 2026

Award recognizes SKYWAN’s role in delivering secure and resilient satellite communications for government and mission-critical…

2 weeks ago